Astria Therapeutics, Inc. (NASDAQ:ATXS) Q4 2022 Earnings Call Transcript

Operator: Good morning and welcome to the Astria Therapeutics 2022 Q4 and Full Year Financial Results and Business Update Conference Call.

Keep Reading →